Inositol for PCOS: The Dose, the Ratio, and What the Trials Found

What Is Inositol, and Does It Actually Do Anything for PCOS?

Nine randomized trials covering 496 women with PCOS found that myo-inositol supplementation measurably lowered fasting insulin and the HOMA insulin-resistance score, according to a 2017 meta-analysis of 247 treated participants against 249 controls. Inositol is a six-carbon, sugar-like molecule from the vitamin B-complex family, and myo-inositol (MI) and D-chiro-inositol (DCI) are the two forms relevant to PCOS. Both act as second messengers in the insulin-signalling pathway — the internal relay that tells a muscle or fat cell to take up glucose once insulin has bound to its receptor. Your body makes some of its own supply from glucose, mainly in the kidney, and tops it up from foods such as citrus fruit, cantaloupe, beans, and whole grains. In PCOS, that signalling relay appears to work less efficiently, which is the theoretical basis for testing an insulin-pathway supplement here in the first place.

That distinction matters going forward: this is not one substance with one dose, and the trials below used different forms, doses, and lengths. None of that changes the basic finding — inositol has a real, modest, insulin-linked effect in PCOS — but it does mean “does inositol work” only has an honest answer once you specify which form, how much, and for how long.

You may also see the condition written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of 56 academic, clinical and patient organisations renamed it. Nothing about the trial evidence below changed with the name. This article uses PCOS because that is still what people search, and PCOS is now PMOS covers the rename itself in full.

What Did the Ovulation and Cycle Trials Actually Find?

In a placebo-controlled trial of 44 obese women with PCOS, 19 of 22 given 1,200 mg of D-chiro-inositol daily ovulated within six to eight weeks, compared with 6 of 22 on placebo — free testosterone fell from 1.1 to 0.5 ng/dL and triglycerides dropped by roughly 40% in the same group. A separate trial of 25 women with oligo- or amenorrhea given 4 g of myo-inositol daily for six months found that 22 of 25 (88%) restored at least one spontaneous cycle, 18 of 25 sustained regular ovulation through follow-up, and 10 pregnancies followed.

What Happens to Insulin and Other Metabolic Markers?

Across nine pooled randomized trials, myo-inositol produced a statistically significant drop in fasting insulin (standardized mean difference −1.02, p = 0.009) and the HOMA-IR score (SMD −0.585, p = 0.041), while the reduction in testosterone fell just short of significance (SMD −0.49, p = 0.099). SHBG — the protein that binds testosterone and lowers what circulates freely — rose significantly only in the trials that ran myo-inositol for 24 weeks or longer, not in the shorter ones. Separately, the 1999 D-chiro-inositol trial found free testosterone fell by more than half and diastolic blood pressure dropped 4 mmHg in the treated group, with no change in the placebo arm.

What Is the Studied Inositol Dosage for PCOS?

Four grams of myo-inositol daily is the dose used in the majority of trials that found an ovulation benefit — Papaleo and Costantino both used exactly this, typically alongside 200–400 mcg of folic acid. Genazzani’s trial used 2 g a day and still restored cyclicity in every amenorrheic or oligomenorrheic participant, so 2 g is not below the effective range; it is simply the lower end of it, tested with fewer participants over a shorter window.

Does the Form You Buy — Powder or Capsule — Change Anything?

Two grams of myo-inositol powder dissolves in a small glass of water in under a minute, which is why most of the trials above used a powder rather than capsules — hitting 4 g a day in capsule form usually means swallowing six to eight pills. Trials split on timing: Papaleo dosed 4 g as two 2 g servings, while Costantino gave the same 4 g total once daily and still restored ovulation in 70% of participants — so splitting the dose is a reasonable default, not a requirement no trial has tested otherwise. Taking it with or without food was not shown to change outcomes in any of the trials cited here.

How Long Does Inositol Take to Work for PCOS?

Twelve to sixteen weeks was long enough to more than triple the ovulation rate in one placebo-controlled trial — 70% versus 21% on placebo — but 24 weeks was the threshold the pooled data needed before SHBG reliably rose. Read together, the trials suggest a rough timeline: measurable insulin and hormonal shifts by 12 weeks, a real change in cycle frequency by 3–4 months, and the fullest metabolic picture — including SHBG — closer to 6 months. Nobody should expect a cycle to normalize inside a single month, and a trial that stops at 8 weeks without change is not evidence of failure; it may simply be evidence of stopping too early relative to what the data actually supports.

Does the Myo-Inositol to D-Chiro-Inositol Ratio Matter?

A 2019 trial that tested seven different myo-inositol-to-D-chiro-inositol ratios in 56 women found that 40:1 outperformed every other combination tested, including DCI alone, and that shifting the ratio toward more DCI reduced the benefit rather than adding to it. That finding is the reason most combination products on the market are formulated at or near 40:1. The full explanation of why that specific ratio exists — the plasma physiology behind it and what happens in the ovary at the wrong ratio — is covered in myo-inositol vs D-chiro-inositol; this page covers dosing, that one covers the ratio itself.

Which PCOS Phenotype Is Inositol Actually Studied In?

All four trials above — sample sizes of 44, 25, 20, and 42 — enrolled women selected for oligo-ovulation, elevated insulin, or being overweight, not lean, regularly-cycling PCOS with normal insulin sensitivity. That is not incidental: inositol’s mechanism runs through the insulin-signalling pathway, so it has more to act on in an insulin-resistant phenotype than in a lean one where insulin is not the driver. Nobody has run a trial that formally sub-groups participants by phenotype and reports inositol’s effect separately for each, so this is mechanistic reasoning rather than a trial finding — reasonable, consistent with why the drug works at all, but not itself proven.

If your pattern is the insulin-resistant or overweight phenotype — the group every trial above actually enrolled — inositol has a plausible mechanism and real trial numbers behind it. If your pattern is lean PCOS with normal fasting insulin, the same mechanism has less to work through, and the honest expectation is a smaller or absent effect, even though no trial has measured that directly. If irregular cycles are driven mainly by high prolactin, thyroid dysfunction, or coming off hormonal birth control, inositol was never tested against those mechanisms and has no reason to help until the underlying driver is addressed.

Who Will Inositol Not Help?

Even without any active ingredient, 21% of women given only folic acid ovulated during one placebo-controlled trial — a reminder that a cycle returning while you happen to be taking inositol is not, on its own, proof the inositol did it; that is exactly why the placebo-controlled numbers elsewhere in this article, not anecdotes, are the ones worth trusting. Inositol also will not help if oligo-ovulation is being driven by something other than PCOS-typical insulin resistance — thyroid disease, hyperprolactinemia, or premature ovarian insufficiency, for example — because those causes sit outside the pathway inositol acts on. And because the testosterone reduction across pooled trials fell short of statistical significance, inositol is not a reliable first choice for androgen-driven symptoms like acne or hirsutism on its own.

Inositol is probably not the right next step if:

• You already ovulate regularly on your own — every trial above specifically enrolled women with oligo- or amenorrhea; none tested inositol in women who already cycle normally.
• Irregular cycles have not yet been worked up for thyroid disease, high prolactin, or premature ovarian insufficiency — inositol does not touch any of those causes.
• You are looking specifically for acne or hair-growth improvement, where the trial evidence is weakest.
• You have already given it a full trial-length course (12 weeks minimum) with no change in cycles or labs — that is a reason to talk to a prescriber, not to extend the same dose indefinitely. See inositol not working? for the fuller checklist before assuming it has failed.

Is Inositol Regulated Like a Drug?

Inositol is sold in most countries as a dietary supplement, not a licensed medicine, which means no regulator checks that a given bottle actually contains the 4 g a trial tested, at the purity the trial used. That is the single biggest practical gap between “myo-inositol works in trials” and “this bottle will do the same thing” — product quality varies by manufacturer, and inositol has never been shown to cure or reverse PCOS regardless of the bottle. Third-party testing certification on the label is the closest a supplement gets to the quality control a prescription drug is required to have.

Two label details matter more than the brand name. First, the ingredient panel should say “myo-inositol” specifically — a vague “inositol blend” does not tell you which isomer, or how much of it, you are actually getting. Second, check the per-serving dose against the trial numbers in Table 2: a product delivering 500 mg or 1 g per serving requires four to eight servings a day to match what the trials actually used, which changes both the cost and the likelihood anyone sticks with it for the 12 or more weeks the evidence says it takes.

If you are weighing inositol against an actual prescription option, the trial-by-trial comparison — including where metformin still wins and where it does not — is laid out in inositol vs metformin for PCOS.

What About Side Effects?

Only the highest tested dose, 12 g a day, produced mild gastrointestinal side effects in a formal safety review — nausea, flatus, and diarrhea — well above the 4 g most ovulation trials used, and severity did not increase with dose beyond that point. The fuller breakdown of what shows up, at what dose, and what the tolerability data does and does not cover is in inositol side effects.

Your Next Step

Three numbers are worth writing down before you start: which form you are taking (myo-inositol, D-chiro-inositol, or a 40:1 combination), how many grams a day, and today’s date, so you can honestly judge “is this working” against the 12-to-24-week timeline the trials actually support — not against a week or two of impatience. If inositol turns out not to be the right fit, the wider supplements and medications section covers the other options with trial evidence behind them.